Published in Neuropsychopharmacology on October 01, 2003
Magnetic Seizure Therapy (MST) for Severe Mood Disorder | NCT00488748
Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST) | NCT03895658
Coil design considerations for deep transcranial magnetic stimulation. Clin Neurophysiol (2013) 2.78
Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacol Ther (2011) 1.29
Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx (2006) 1.19
Advances in the treatment of depression. NeuroRx (2006) 1.03
Electric field strength and focality in electroconvulsive therapy and magnetic seizure therapy: a finite element simulation study. J Neural Eng (2011) 1.01
Electroconvulsive therapy stimulus parameters: rethinking dosage. J ECT (2010) 1.01
Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry (2008) 1.00
Electroconvulsive therapy and its different indications. Dialogues Clin Neurosci (2008) 0.99
Brain stimulation in posttraumatic stress disorder. Eur J Psychotraumatol (2011) 0.98
Brain stimulation in psychiatry and its effects on cognition. Nat Rev Neurol (2010) 0.98
Repetitive transcranial magnetic stimulator with controllable pulse parameters. J Neural Eng (2011) 0.97
Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review. Brain Stimul (2010) 0.96
Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biol Psychiatry (2008) 0.94
Treatment strategies to improve and sustain remission in major depressive disorder. Dialogues Clin Neurosci (2008) 0.94
Focal electrically administered seizure therapy: a novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction. Neuropsychopharmacology (2009) 0.93
Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging. Dialogues Clin Neurosci (2013) 0.90
Individualized Low-Amplitude Seizure Therapy: Minimizing Current for Electroconvulsive Therapy and Magnetic Seizure Therapy. Neuropsychopharmacology (2015) 0.87
Unaltered neuronal and glial counts in animal models of magnetic seizure therapy and electroconvulsive therapy. Neuroscience (2009) 0.86
Effect of anatomical variability on electric field characteristics of electroconvulsive therapy and magnetic seizure therapy: a parametric modeling study. IEEE Trans Neural Syst Rehabil Eng (2014) 0.85
Translational development strategy for magnetic seizure therapy. Exp Neurol (2009) 0.85
Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities. Dialogues Clin Neurosci (2006) 0.82
Meta-analysis of initial seizure thresholds in electroconvulsive therapy. Eur Arch Psychiatry Clin Neurosci (2009) 0.82
Emerging targets for antidepressant therapies. Curr Opin Chem Biol (2009) 0.82
Somatic treatments for mood disorders. Neuropsychopharmacology (2011) 0.82
Future prospects in depression research. Dialogues Clin Neurosci (2006) 0.81
Comparison of electric field strength and spatial distribution of electroconvulsive therapy and magnetic seizure therapy in a realistic human head model. Eur Psychiatry (2016) 0.80
Magnetic Seizure Therapy for Unipolar and Bipolar Depression: A Systematic Review. Neural Plast (2015) 0.80
Novel targets for antidepressant therapies. Curr Psychiatry Rep (2008) 0.80
A systematic review of the neurocognitive effects of magnetic seizure therapy. Int Rev Psychiatry (2011) 0.79
Differential heart rate response to magnetic seizure therapy (MST) relative to electroconvulsive therapy: a nonhuman primate model. Neuroimage (2009) 0.78
Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy. J ECT (2014) 0.78
Disruption of component processes of spatial working memory by electroconvulsive shock but not magnetic seizure therapy. Int J Neuropsychopharmacol (2012) 0.77
Treatment-resistant Late-life Depression: Challenges and Perspectives. Curr Neuropharmacol (2015) 0.77
Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report. Neuropsychiatr Dis Treat (2014) 0.77
Neuromodulation for treatment-resistant depression. F1000 Med Rep (2012) 0.76
Update on Neuromodulation for Treatment-Resistant Depression. F1000Res (2015) 0.76
Neuromodulation for mood and memory: from the engineering bench to the patient bedside. Curr Opin Neurobiol (2014) 0.75
Advances in the Management of Treatment-Resistant Depression. Focus (Am Psychiatr Publ) (2010) 0.75
Expanded Safety and Efficacy Data for a New Method of Performing Electroconvulsive Therapy: Focal Electrically Administered Seizure Therapy. J ECT (2016) 0.75
Neuro-stimulation Techniques for the Management of Anxiety Disorders: An Update. Clin Psychopharmacol Neurosci (2016) 0.75
[Brain stimulation methods for resistance to therapy]. Nervenarzt (2007) 0.75
An overview on clinical aspects in magnetic seizure therapy. J Neural Transm (Vienna) (2016) 0.75
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials (2004) 6.64
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry (2007) 5.59
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am (2003) 5.05
Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry (2004) 3.84
Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry (2010) 3.14
Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. Br J Psychiatry (2005) 2.84
Parietal cortex and representation of the mental Self. Proc Natl Acad Sci U S A (2004) 2.73
Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry (2003) 2.61
Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry (2010) 2.46
Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Aff (Millwood) (2011) 2.34
Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology (2008) 2.31
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry (2005) 2.24
Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry (2004) 2.24
Response inhibition predicts poor antidepressant treatment response in very old depressed patients. Am J Geriatr Psychiatry (2007) 2.18
Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci (2007) 2.12
Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol (2003) 2.08
Adequacy of antidepressant treatment after discharge and the occurrence of suicidal acts in major depression: a prospective study. Am J Psychiatry (2002) 1.95
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry (2005) 1.90
Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. J Clin Psychiatry (2006) 1.90
A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput (2005) 1.78
Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry (2007) 1.76
Good vibrations: cross-frequency coupling in the human nucleus accumbens during reward processing. J Cogn Neurosci (2009) 1.69
Vascular depression: A distinct diagnostic subtype? Biol Psychiatry (2006) 1.66
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT (2013) 1.62
Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects. Neuroimage (2003) 1.62
Absence of histological lesions in primate models of ECT and magnetic seizure therapy. Am J Psychiatry (2004) 1.60
Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. Am J Psychiatry (2004) 1.59
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry (2005) 1.57
Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol (2002) 1.51
A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry (2005) 1.48
Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates. PLoS One (2011) 1.45
Stimulating personality: ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes. Biotechnol J (2008) 1.44
Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology (2012) 1.38
Correlates of trait impulsiveness in performance measures and neuropsychological tests. Psychiatry Res (2005) 1.36
Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Arch Gen Psychiatry (2009) 1.33
Cross-species affective functions of the medial forebrain bundle-implications for the treatment of affective pain and depression in humans. Neurosci Biobehav Rev (2010) 1.28
Fear processing and social networking in the absence of a functional amygdala. Biol Psychiatry (2012) 1.23
Nuclei accumbens phase synchrony predicts decision-making reversals following negative feedback. J Neurosci (2009) 1.21
A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression. J Clin Psychiatry (2003) 1.21
Intracranial EEG correlates of expectancy and memory formation in the human hippocampus and nucleus accumbens. Neuron (2010) 1.20
Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry (2002) 1.17
Depression comorbidity in spinocerebellar ataxia. Mov Disord (2011) 1.15
Focal electrical stimulation as a sham control for repetitive transcranial magnetic stimulation: Does it truly mimic the cutaneous sensation and pain of active prefrontal repetitive transcranial magnetic stimulation? Brain Stimul (2008) 1.13
Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology (2003) 1.13
Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res (2010) 1.09
Direct injection of noise to the visual cortex decreases accuracy but increases decision confidence. J Neurophysiol (2011) 1.09
Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry (2015) 1.09
Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). Int J Neuropsychopharmacol (2005) 1.08
Open-label trial of riluzole in generalized anxiety disorder. Am J Psychiatry (2005) 1.07
Neurophysiological characterization of magnetic seizure therapy (MST) in non-human primates. Suppl Clin Neurophysiol (2003) 1.05
Cognitive reserve-mediated modulation of positron emission tomographic activations during memory tasks in Alzheimer disease. Arch Neurol (2004) 1.05
Deep brain stimulation in movement and psychiatric disorders. Biol Psychiatry (2006) 1.05
Neuroelectric signatures of reward learning and decision-making in the human nucleus accumbens. Neuropsychopharmacology (2008) 1.03
Sertraline treatment of elderly patients with depression and cognitive impairment. Int J Geriatr Psychiatry (2003) 1.01
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. Int J Geriatr Psychiatry (2008) 1.01
The N-methyl-D-aspartate receptor co-agonist D-cycloserine facilitates declarative learning and hippocampal activity in humans. Biol Psychiatry (2010) 1.01
Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks. J ECT (2011) 0.99
Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation. World J Biol Psychiatry (2011) 0.99
Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol (2010) 0.98
Predictors of remission after electroconvulsive therapy in unipolar major depression. J Clin Psychiatry (2005) 0.98
Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study. Am J Psychiatry (2004) 0.98
Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res (2004) 0.98
Mood improvement after deep brain stimulation of the internal globus pallidus for tardive dyskinesia in a patient suffering from major depression. J Psychiatr Res (2006) 0.97
Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry (2007) 0.96
Age-related characteristics of depression: a preliminary STAR*D report. Am J Geriatr Psychiatry (2005) 0.96
Reduced 5-HT(2A) receptor signaling following selective bilateral amygdala damage. Soc Cogn Affect Neurosci (2008) 0.95
Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biol Psychiatry (2008) 0.94
Electrodes in the brain--ethical criteria for research and treatment with deep brain stimulation for neuropsychiatric disorders. Brain Stimul (2010) 0.94
A primate model of anterograde and retrograde amnesia produced by convulsive treatment. J ECT (2004) 0.94
Acceptability of second-step treatments to depressed outpatients: a STAR*D report. Am J Psychiatry (2007) 0.93
Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. Ann Clin Psychiatry (2007) 0.93
Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex affects divided attention immediately after cessation of stimulation. J Psychiatr Res (2005) 0.93
Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS). Brain Stimul (2009) 0.92
Pulse width dependence of motor threshold and input-output curve characterized with controllable pulse parameter transcranial magnetic stimulation. Clin Neurophysiol (2013) 0.92
Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex. Psychiatry Res (2011) 0.92
Diffusion tensor imaging and neuromodulation: DTI as key technology for deep brain stimulation. Int Rev Neurobiol (2012) 0.92
Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT. J Affect Disord (2012) 0.91
A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease. Int J Geriatr Psychiatry (2010) 0.91
Self-specific processing in the default network: a single-pulse TMS study. Exp Brain Res (2010) 0.91
Noradrenergic enhancement of amygdala responses to fear. Soc Cogn Affect Neurosci (2009) 0.90
Electroconvulsive therapy in treatment-resistant schizophrenia: prediction of response and the nature of symptomatic improvement. J ECT (2010) 0.90
Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety (2011) 0.90
A feasibility study of a new method for electrically producing seizures in man: focal electrically administered seizure therapy [FEAST]. Brain Stimul (2013) 0.89
A neuromodulation experience registry for deep brain stimulation studies in psychiatric research: rationale and recommendations for implementation. Brain Stimul (2011) 0.89
Focal electrically administered therapy: device parameter effects on stimulus perception in humans. J ECT (2009) 0.89
Response to Drs Abrams and Kellner: the cognitive effects of ECT in community settings. J ECT (2007) 0.88
Neurophysiological characterization of high-dose magnetic seizure therapy: comparisons with electroconvulsive shock and cognitive outcomes. J ECT (2009) 0.88
Adverse life events in elderly patients with major depression or dysthymic disorder and in healthy-control subjects. Am J Geriatr Psychiatry (2002) 0.88
Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial. Brain Stimul (2012) 0.88
Antidepressant effects of repetitive transcranial magnetic stimulation in the elderly: correlation between effect size and coil-cortex distance. Arch Gen Psychiatry (2002) 0.87
Ethical guidance for the management of conflicts of interest for researchers, engineers and clinicians engaged in the development of therapeutic deep brain stimulation. J Neural Eng (2011) 0.87
Baseline severity of depression predicts antidepressant drug response relative to escitalopram. Expert Opin Pharmacother (2009) 0.86
Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. Depress Anxiety (2012) 0.86
A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry (2014) 0.86
Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride. Neuropsychopharmacology (2005) 0.86